Cargando…

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention

Recent studies and guidelines have indicated that lipoprotein(a) [Lp(a)]was an independent risk factor of arteriosclerotic cardiovascular disease (ASCVD). This study aimed to determine the relationship between serum Lp(a) levels and the risk of periprocedural myocardial injury following percutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhuoshan, Shui, Xing, Ling, Yesheng, Zhou, Linli, Shi, Wenqi, Luo, Yanting, Li, Suhua, Zhu, Jieming, Yu, Shujie, Liu, Jinlai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852163/ https://www.ncbi.nlm.nih.gov/pubmed/33289114 http://dx.doi.org/10.1002/clc.23520

Ejemplares similares

Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
por: Li, Suhua, et al.
Publicado: (2020)

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial
por: Huang, Zhuoshan, et al.
Publicado: (2023)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
por: Ueki, Yasushi, et al.
Publicado: (2022)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study
por: Buturak, Ali, et al.
Publicado: (2016)

Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Shibata, Yohei, et al.
Publicado: (2017)

Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2021)

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Jian, Wen, et al.
Publicado: (2020)

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
por: Verdoia, M., et al.
Publicado: (2016)

Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta‐analysis
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions
por: Januszek, Rafał, et al.
Publicado: (2018)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020)

Coronary plaque morphology on multi-modality imagining and periprocedural myocardial infarction after percutaneous coronary intervention()
por: Sato, Akira, et al.
Publicado: (2016)

Periprocedural temporary pacing in primary percutaneous coronary intervention for patients with acute inferior myocardial infarction
por: Hwang, You Mi, et al.
Publicado: (2016)

Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction
por: Kim, Seung-Hyun, et al.
Publicado: (2021)

Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention
por: Negro, Federica, et al.
Publicado: (2021)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction
por: Kodesh, Afek, et al.
Publicado: (2023)

Prognostic implications of calculated Apo‐lipoprotein B in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points
por: Ghodsi, Saeed, et al.
Publicado: (2021)

Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease
por: Shui, Xing, et al.
Publicado: (2021)

Exploring the Association of Fibrinogen and CRP with the Clinical Spectrum of CAD and Periprocedural Outcomes in Patients Undergoing Percutaneous Coronary Interventions
por: Khandelwal, Vijay, et al.
Publicado: (2022)

Long-term outcomes of periprocedural coronary dissection and perforation for patients undergoing percutaneous coronary intervention in a Japanese multicenter registry
por: Kuno, Toshiki, et al.
Publicado: (2023)

LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention
por: Chen, Xuefeng, et al.
Publicado: (2021)

Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention
por: Zhang, Zhenmin, et al.
Publicado: (2022)

COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy
por: Cole, Justin, et al.
Publicado: (2022)

Total Thrombus‐formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Oimatsu, Yu, et al.
Publicado: (2017)

Folic Acid Attenuates Contrast-Induced Nephropathy in Patients With Hyperhomocysteinemia Undergoing Coronary Catheterization: A Randomized Controlled Trial
por: Peng, Long, et al.
Publicado: (2021)

Risk Factors of Periprocedural Bradycardia during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction
por: Li, Yong, et al.
Publicado: (2019)

Peripheral Artery Tonometry Reveals Impaired Endothelial Function before Percutaneous Coronary Intervention in Patients with Periprocedural Myocardial Injury
por: Chen, Zhangwei, et al.
Publicado: (2021)

Periprocedural Hemoglobin Drop and Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients
por: Lee, Kang Hyu, et al.
Publicado: (2010)

Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2022)

Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
por: Liu, Mei-Jun, et al.
Publicado: (2020)

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study
por: Qin, Zheng, et al.
Publicado: (2019)

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Khalfallah, Mohamed, et al.
Publicado: (2022)

Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction
por: Chen, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_shpv0hb9a5ddtunaq4ssqo0klj